The gut microbiota, associated diseases and possible treatments: A narrative review




Microorganisms; Microbiome; Pathologies; Dysbiosis; Neurotransmitters.


The microbiota is made up of several microorganisms, bacteria, viruses and fungi that inhabit the human body, carrying out mutualistic processes. This mechanism directly interferes with the digestion and absorption of nutrients, protection against pathogenic organisms, regulation of the immune system, and enzymatic functions that act as stimulators and precursors of substances involved in various metabolic processes of the host. This review aims to describe the functions of the gut microbiota, together with the existing microorganisms of the human gut, which is one of the largest in diversity, number and functions performed. Studies were analyzed using databases such as Periódico CAPES, SciELO and LILACS and PubMed, covering publications between 1990 and 2022. The gut microbiota is responsible for maintaining gut homeostasis, in which it prevents the development of pathogens and infectious agents. There is a relationship between increased inflammatory rates and gut dysbiosis, which may be associated with improper diets, consumption of toxic and chemical products, as well as genetic and environmental factors that can suppress or trigger the increase in harmful bacteria. The determinants of the gut microbiota were addressed. The relationship between the brain and the gut and the influence of the microbiota on obesity, the immune system, the development of neurological diseases and cancer were discussed. The role of the microbiota in pseudomembranous colitis has been presented. It was possible to understand that dysbiosis triggers several innate and adaptive immune responses that can develop the formation of several harmful processes for the host. It is concluded that the intestinal microbiota plays an essential role in maintaining the homeostasis of the intestine through the host's immune system, and evolves with it, influencing the metabolism, physiology and development of the immune system, while disruption of the microbial community can result in chronic diseases.

Author Biographies

Maria Eduarda Garcia de Andrade, Universidade Federal de Sergipe

Graduanda do curso de Licenciatura em Ciências Biológicas da Universidade Federal de Sergipe, Campus Professor Alberto Carvalho, Itabaiana, Se.

Célia Gomes de Siqueira, Universidade Federal de Sergipe

Doutora em Microbiologia Aplicada pela UNESP de Rio Claro, SP, Docentes da Universidade Federal de Sergipe, Campus Professor Alberto Carvalho, Itabaiana, SE.


Abdelsalam, N. A., Ramadan, A. T., ElRakaiby, M. T., & Aziz, R. K. (2020). Toxicomicrobiomics: The Human Microbiome vs. Pharmaceutical, Dietary, and Environmental Xenobiotics. Frontiers in pharmacology, 11, 390.

Almeida, J. R. M., Collares, D., & Barbosa, P. (2015). Bioprospecção microbiana. Embrapa Agroenergia.

Almeida, K. A., Strunz, C. M. C., Maranhão, R. C. & Mansur, A. P. (2007). Polimorfismo S447X da lipase lipoprotéica: influência sobre a incidência de doença arterial coronariana prematura e sobre os lípides plasmáticos. Arquivos Brasileiros de Cardiologia, 88(3), 297-303.

Altveş, S., Yildiz, H. K. & Vural, H. C. (2020). Interaction of the microbiota with the human body in health and diseases. Biosci Microbiota Food Health, 39(2), 23-32.

Anderson, N. B. & Armstead, C. A. (1995). Toward understanding the association of socioeconomic status and health: a new challenge for the biopsychosocial approach. Psychosom. Med., 57(3), 213–25.

Andrucioli, M. C. D., Faria, G., Nelson-Filho, P., Romano, F. L. & Matsumoto, M. A. N. (2017). Influence of resin-modified glass ionomer and tropical fluoride on levels of Streptococcus mutans in saliva and biofilm adjacent to metallic brackets. Journal of Applied Oral Science, 25(2),196-202.

Bajinka, O., Darboe, A., Tan, Y., Abdelhalim, K. A. & Cham, L. B. (2020). Gut microbiota and the human gut physiological changes. Annals of Microbiology, 70(65), 1-9.

Barbosa, F. H. F. Martins, F. S. Barbosa, L. P. J. L. & Nico, J. R. (2010). Microbiota indígena do trato gastrintestinal. Revista de Biologia e Ciência da Terra, Aracaju, 10(1), 78-93.

Bodén, S., Myte, R., Wennberg, M., Harlid, S., Johansson, I. et al. (2019). The inflammatory potential of diet in determining cancer risk; A prospective investigation of two dietary pattern scores. PloS One, 14(4), 1-16.

Bull, M. J. & Plummer, N. T. (2014). Part 1: The Human Gut Microbiome in Health and Disease. Integr Med (Encinitas), 13(6), 17–22.

Butler, M. I., Mörkl, S., Sandhu, K. V., Cryan, J. F. & Dinan, T. G. (2019). The gut microbiome and mental health: what should we tell our patients? The Canadian Journal of Psychiatry, 64(11), 747–760.

Campos, H. S. (2018). Papel do microbioma na resposta imune e na asma. Arq Asma Alerg Imunol., 2(2), 238-246.

Cani, P. D. & Delzonne, N. M. (2007). Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care, 10(6), 729-734.

Chen, Y., Xu, J., & Chen, Y. (2021). Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders. Nutrients, 13(6), 2099.

Clark, A. & Mach, N. (2016). Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes. Journal of the International Society of Sports Nutrition, 13, 43.

Clemente, J. C., Ursell, L. K., Parfrey, L. W. & Knight, R. (2012). The impact of the gut microbiota on human health: An integrative view. Cell, 148(6), 1258-1270.

Costa, C. S. G. (2021). A Importância da microbiota intestinal na saúde e em estados de disbiose – revisão narrativa. Dissertação (Mestrado em Ciências Farmacêuticas), Universidade Fernando Pessoa, Porto, 1-58.

Costa, S. E. & Varavallo, A. M. (2011). Probióticos e Prebióticos: Relações com a imunidade e promoção da saúde. Revista Científica do ITPAC, 4(2), 4-11.

Cotrim, M. A., Marzano, L. A. S., Batista, J. P. T., Lira, M. L. C. & Fraga, C. L. (2020). O papel da microbiota intestinal na patogênese das doenças inflamatórias intestinais. Brazilian Journal of Health Review, 3(3), 4558–4565.

Cryan, J. F. & O'mahony, S. M. (2011). The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil, 23(3), 187-192.

Cryan, J. F., O'riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S. et al. (2019). The microbiota–gut–brain axis. Physiol., 99, 1877–2013.

Cullin, N., Azevedo Antunes, C., Straussman, R., Stein-Thoeringer, C. K. & Elinav, E. (2021). Microbiome and cancer. Cancer cell, 39(10), 1317–1341.

Czepiel, J., Dróżdż, M., Pituch, H., Kuijper, E. J., Perucki, W., Mielimonka, A., Goldman, S., Wultańska, D., Garlicki, A., & Biesiada, G. (2019). Clostridium difficile infection: review. European journal of clinical microbiology & infectious diseases, 38(7), 1211–1221.

Daisley, B. A., Monachese, M., Trinder M., Bisanz, J. E., Chmiel, J. A., Burton, J. P. & Reida, G. (2019). Immobilization of cadmium and lead by Lactobacillus rhamnosus GR-1 mitigates apical-to-basolateral heavy metal translocation in a Caco-2 model of the intestinal epithelium. Gut Microbes, 10, 321–33.

El-Enshasy, H. A. & Yang, S. T. (2021). Probiotics, the Natural Microbiota in Living Organisms: Fundamentals and Applications. Boca Raton: CRC Press.

Faintuch, J. (2017). Microbioma, disbiose, probióticos e bacterioterapia. Barueri, SP: Editora Manole LTDA.

Fan, X., Alekseyenko, V., Wu, J., Peters, B. A., Jacobs, E., Gapstur, S. M. et al. (2018). Human oral microbiota and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut, 67(1), 120–27.

Farooq, P. D., Urrunaga, N. H., Tang, D. M., & von Rosenvinge, E. C. (2015). Pseudomembranous colitis. Disease-a-month : DM, 61(5), 181–206.

Fatima, R. & Aziz, M. (2019). The Hypervirulent Strain of Clostridium Difficile: NAP1/B1/027 - A Brief Overview. Cureus, 11(1), e3977.

Fernández, M. F., Reina-Pérez, I., Astorga, J. M., Rodríguez-Carrillo, A., Plaza-Díaz, J. & Fontana, L. Breast Cancer and Its Relationship with the Microbiota. International journal of environmental research and public health, 15(8), 1747.

Fonseca, P. C. & Pinheiro, M. S. (2019). Influência da microbiota intestinal no desenvolvimento da obesidade: artigo de revisão. Caderno De Graduação - Ciências Biológicas E Da Saúde, Aracaju, 5(2), 193-212.

Forsythe, P. (2013). Gut microbes as modulators of neuro-immuno-endocrine system. PharmaNutrition, 1(4), 115–122.

Forsythe, P., Sudo, N., Dinan, T., Taylor, V. & Bienenstock, J. (2010). Mood and gut feelings. Brain, Behavior, and Immunity, 24, 1, 9-16.

Foster, J. & Neufeld, K. M. (2013). Gut-brain axis: how the microbiome influences anxiety and depression. Trends in Neurosciences, 36(5), 305-312.

Furuhashi, M., Tuncman, G., Görgün, C. Z., Makowski, L., Atsumi, G. et al. (2007). Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature, 21(447), 959-65.

Garrett, W. S. (2015). Cancer and the microbiota. Science, 3(348), 80-6.

Gaudino, S. J. & Kuma, P. (2019). Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis. Front Immunol., 6(10), 360.

Geuking, M. B., Köller, Y., Rupp, S. & Mccoy, K. D. (2014). The interplay between the gut microbiota and the immune system. Gut Microbes, 5(3), 411–418.

Gonçalves, P. A. M. (2014). Microbiota – implicações na imunidade e no metabolismo. Dissertação de Mestrado em Ciências Farmacêuticas). Universidade Fernando Pessoa, Porto, Portugal.

Guarner, F. (2007). Papel de la flora intestinal en la salud y en la enfermedad. Nutrición Hospitalaria, Madrid, 22(2), 14-19.

Hadrich, D. (2018). Microbiome research is becoming the key to better understanding health and nutrition. Frontiers in genetics, 9, 212.

Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Bjorkholm, B., Samuelsson, A. et al. (2011). Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. USA, 108(7), 3047-3052.

Hvas, C. L., Baunwalla, S. M. D., & Erikstrup, C. (2020). Faecal microbiota transplantation: A life-saving therapy challenged by commercial claims for exclusivity. EClinicalMedicine, 24, 100436.

Karkman, A., Lehtimäki, J. & Ruokolainen, L. (2017). The ecology of human microbiota: dynamics and diversity in health and disease. Annals of the New York Academy of Sciences, 1399(1), 78–92.

Kim, K. O. & Gluck, M. (2019). Fecal Microbiota Transplantation: An Update on Clinical Practice. Clinical endoscopy, 52(2), 137–143.

Koren, O., Knights, D., Gonzalez, A., Waldron, L., Segata, N., Knight, R. et al. (2013). A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets. PLoS Comput Biol., 9(1), e1002863.

Korman, T. M. (2015). Diagnosis and management of Clostridium difficile infection. Semin Respir Crit Care Med., 36(1), 31-43.

Ley R. E., Backhed F., Turbanugh, P., Lozupone, C. A., Knight, R. D. & Gordon, J. I. (2005). Obesity alters gut microbial ecology. Nature USA, 102(31), 1022-23.

Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. (2006). Human gut microbes associated with obesity. Nature, 444(7122), 1022–1023.

Longo, W. E., & Oliver, G.C. (2007). Less-common Benign Disorders of the Colon and Rectum. In: Wolff, B.G., et al. The ASCRS Textbook of Colon and Rectal Surgery. Springer, New York, NY.

Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K. & Knight, R. (2012). Diversity, stability and resilience of the human gut microbiota. Nature, 489(7415), 220-230.

Magalhães-Guedes, K. T., Anunciação, T. A. & Nascimento, A. S. M. (2020). Psicobióticos na saúde mental contra transtorno da ansiedade e depressão. cap. 13, 105-110. Castro, L. H. A., Pereira, T. T., Oesterreich, S. A. (Orgs). In: Ciências da saúde: campo promissor em pesquisa. (vol. 1, 1ª ed, 2020). Ponta Grossa, PR: Atena.

Margolis, K. G., Cryan, J. F., & Mayer, E. A. (2021). The Microbiota-Gut-Brain Axis: From Motility to Mood. Gastroenterology, 160(5), 1486–1501.

Markowiak, P. & Śliżewska, K. (2017). Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients, 9(9), 1021.

Marmot, M. (2006). Smoking and inequalities. The Lancet, 368(9533), 341–42.

Martin, R., Nauta, A. J., Ben Amor, K., Knippels, L. M. J., Knol, J. & Garssen, J. (2010). Early life: gut microbiota and immune development in infancy. Beneficial Microbes, 1(4), 367-382.

Martins, D. C., Baptista, C. & Carrilho, C. (2018). Microbiota intestinal e diabetes mellitus: associações intrínsecas. Rev Port Endocrinol Diabetes Metab., 13(2).

Meng, C., Bai, C., Brown, T. D., Hood, L. E. & Tian, Q. (2018). Human Gut Microbiota and Gastrointestinal Cancer. Genomics, proteomics & bioinformatics, 16(1), 33–49.

Microbiology By Numbers. (2011). Nature reviews microbiology, 9, 628.

Morais, L. H., Schreiber, H. L. & Mazmanian, S. K. (2021). The gut microbiota–brain axis in behaviour and brain disorders. Nature reviews microbiology, 19, 241–255.

Nishijima, S., Suda, W., Oshima, K., Kim, S. W., Hirose, Y., Morita, H. & Hattori, M. (2016). The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res., 23, 125–33.

Pandey, K. R., Naik, S. R. & Vakil, B. V. (2015). Probiotics, prebiotics and synbiotics- a review. Journal of Food Science and Technology, 52(12), 7577–7587.

Peters, B. A., Wu, J., Pei, Z., Yang, L., Purdue, M. P., Freedman, N. D. et al. (2017). Oral microbiome composition reflects prospective risk for esophageal cancers. Cancer Res., 77(23), 6777–87.

Postelli, G. & Costa, C. (2010). Bactérias intestinais e obesidade. Revista saúde e pesquisa, 3(1), 115-119.

Rossen, N. G., Macdonald, J. K., De Vries, E. M., D’haens, G. R., De Vos, W. M. et al. (2015). Fecal microbiota transplantation as novel therapy in gastroenterology: a systematic review. World J Gastroenterol., 21(17), 5359-71.

Santos, K. E. R. & Ricci, G. C. L. (2016). Microbiota intestinal e a obesidade. Revista UNINGÁ Review, 26(1),74-82.

Santos, L. A. (2018). A Microbiota intestinal e sua relação com o sistema imunológico. Revista da Universidade Vale do Rio Verde, 16(1), 1-9.

Santos, R. & Varavalho, M. (2011). A importância de probiótico para o controle e/ou reestruturação da microbiota intestinal. Revista Científica do ITPAC, São Paulo, 4(1), 40-49.

Sender R., Fuchs S. & Milo R. (2016). Revised estimates for the number of human and bacteria cells in the body. PLoS biology, 14(8), e1002533.

Signorello, L. B., Cohen, S. S., Williams, D. R., Munro, H. M., Hargreaves, M. K. & Blot, W. J. (2014). Socioeconomic status, race, and mortality: a prospective cohort study. Am. J. Public Health, 104(12), 98–107.

Sommer, F. & Backhed, F. (2013). The gut microbiota - masters of host development and physiology. Nature reviews microbiology, 11, 227–238.

Tan, P., Li, X., Shen, J., & Feng, Q. (2020). Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update. Frontiers Pharmacology, 11:574533. doi: 10.3389/fphar.2020.574533

Tan, H. E. (2023). The microbiota-gut-brain axis in stress and depression. Frontiers in neuroscience, 17, 1151478.

Tang, W. W. H., Bäckhed, F., Landmesser, U. L. F & Hazen, S. L. (2019). Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review. J Am Coll Cardiol., 73(16), 2089–2105.

Terrier, M. C. Z., Simonet, Ml, B. P. & Frossard, J. L. (2014). Recurrent Clostridium difficile infections: the importance of the intestinal microbiota. World J Gastroenterol., 20(23), 7416-23.

The Integrative Hmp (iHMP). (2019). Research Network Consortium. The Integrative Human Microbiome Project. Nature, 569, 641–648.

Tsukumo, D. M., Carvalho, B. M., Carvalho-Filho, M. A. & Saad, M. J. A. (2009). Translational research into gut microbiota: new horizons in obesity treatment. Arq Bras Endocrinol Metabol., 53(2), 139-44.

Wachsmuth, H.R., Weninger, S.N. & Duca, F.A. (2022). Role of the gut–brain axis in energy and glucose metabolism. Experimental & Molecular Medicine, 54, 377–392.

Waclawiková, B., Codutti, A., Alim, K., & El Aidy, S. (2022). Gut microbiota-motility interregulation: insights from in vivo, ex vivo and in silico studies. Gut microbes, 14(1), 1997296.

Wilson, I. D. & Nicholson, J. K. (2017). Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Transl. Res., 179, 204–22.

Zahran, S. A., Ali-Tammam, M., Hashem, A. M., Aziz, R. K. & Ali, A. E. (2019). Azoreductase activity of dye-decolorizing bacteria isolated from the human gut microbiota. Scientific reports, 9(1), 5508.

Zhou, X., Qiao, K., Wu, H., & Zhang, Y. (2023). The Impact of Food Additives on the Abundance and Composition of Gut Microbiota. Molecules (Basel, Switzerland), 28(2), 631.



How to Cite

ANDRADE, M. E. G. de .; SIQUEIRA, C. G. de . The gut microbiota, associated diseases and possible treatments: A narrative review. Research, Society and Development, [S. l.], v. 13, n. 1, p. e6113141719, 2024. DOI: 10.33448/rsd-v13i1.41719. Disponível em: Acesso em: 25 jun. 2024.



Health Sciences